Therapeutic Efficacy of Topical Epigallocatechin Gallate in Murine Dry Eye

Abstract

Topical EGCG treatment is able to reduce the clinical signs and inflammatory changes in DED by suppressing the inflammatory cytokine expression and infiltration of CD11b+ cells in the cornea.